Numerous human and animal studies have highlighted the chemokine CCL2 (formerly known as MCP-1[1]) as a critical mediator of the neuroinflammatory disease multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE)[2-4]. The gene discussed is CCL2; the disease is myeloid sarcoma.